Quinupristin dalfopristin contraindications: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Quinupristin dalfopristin }} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DA..." |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
==Contraindications== | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher = | date = | accessdate = }}</ref> | Synercid is contraindicated in patients with known hypersensitivity to Synercid, or with prior hypersensitivity to other [[streptogramins]] (e.g., [[pristinamycin]] or [[virginiamycin]]). <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = SYNERCID (QUINUPRISTIN AND DALFOPRISTIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=28f698df-b584-4455-2e94-6efc41313960 | publisher = | date = | accessdate = }}</ref> | ||
Latest revision as of 05:39, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Contraindications
Synercid is contraindicated in patients with known hypersensitivity to Synercid, or with prior hypersensitivity to other streptogramins (e.g., pristinamycin or virginiamycin). [1]
References
Adapted from the FDA Package Insert.